AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25633257
Drug: Bone-anchored suspension
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone-anchored suspension technique (BAST)
Trial: 21811136
Drug: Cobicistat 150
RxNorm normalized name: cobicistat 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cobicistat 150 mg with atazanavir and emtricitabine/tenofovir df
Trial: 21811136
Drug: Ritonavir 100
RxNorm normalized name: ritonavir 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir 100 mg with atazanavir and emtricitabine/tenofovir df
Trial: 19726078
Drug: Clopidogrel (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (600 mg loading dose) with PPI
Trial: 19726078
Drug: Clopidogrel (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (600 mg loading dose) without PPI
Trial: 19726078
Drug: Prasugrel (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel (60 mg loading dose) with PPI
Trial: 19726078
Drug: Prasugrel (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel (60 mg loading dose) without PPI
Trial: 15296999
Drug: Follow-up investigation
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Follow-up investigation after optimising therapy in narcolepsy patients
Trial: 11255137
Drug: 1.0-g glycerol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0-g glycerol x kg body weight(-1) + 30% of the total rehydration water volume (GLY)
Trial: 9249117
Drug: Epidural meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural meperidine 25 mg diluted with saline to 2 mL (12.5 mg/mL)
Trial: 9249117
Drug: Epidural meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural meperidine 25 mg diluted with saline to 5 mL (5 mg/mL)
Trial: 9249117
Drug: Epidural meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural meperidine 25 mg diluted with saline to 10 mL (2.5 mg/mL)
Trial: 8074624
Drug: Phenytoin 200
RxNorm normalized name: phenytoin 200 mg oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenytoin 200 mg
Trial: 31790543
Drug: Fenfluramine, 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenfluramine, 0.4 mg/kg/d (maximum, 17 mg/d)
Trial: 24942766
Drug: Olmesartan/Amlodipine 10/5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan/Amlodipine 10/5 mg
Trial: 24942766
Drug: Olmesartan/Amlodipine 20/5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan/Amlodipine 20/5 mg
Trial: 24942766
Drug: Olmesartan/Amlodipine 40/5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan/Amlodipine 40/5 mg
Trial: 24942766
Drug: Olmesartan/Amlodipine 40/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan/Amlodipine 40/10 mg
Trial: 18294111
Drug: Once-daily abacavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily abacavir 600 mg-lamivudine 300 mg
Trial: 18294111
Drug: Twice-daily abacavir
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily abacavir 300 mg and lamivudine 150 mg
Trial: 15307433
Drug: Sulfadoxine-pyrimethamine (SP)
RxNorm normalized name: pyrimethamine / sulfadoxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfadoxine-pyrimethamine (SP) alone (1.25 mg/kg based on pyrimethamine)
Trial: 15307433
Drug: Artesunate plus
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Artesunate plus SP (1 dose: 4 mg/kg/d for 1 day)
Trial: 15307433
Drug: Artesunate plus
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Artesunate plus SP (3 doses: 4 mg/kg/d for 3 days)
Trial: 10884466
Drug: Transcranial Doppler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial Doppler ultrasound with Valsalva maneuver (VM) for 5 seconds starting 5 seconds after the beginning of contrast injection
Trial: 10884466
Drug: Transcranial Doppler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial Doppler ultrasound with VM for 5 seconds starting 2 seconds after the beginning of contrast injection
Trial: 10884466
Drug: Transcranial Doppler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial Doppler ultrasound with VM for 5 seconds starting 8 seconds after the beginning of contrast injection
Trial: 10884466
Drug: Transcranial Doppler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial Doppler ultrasound with repetitive short VMs in between 2 and 13 seconds after the beginning of contrast injection
Trial: 3549705
Drug: Phenelzine 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenelzine 75 mg
Trial: 12707430
Drug: Imipramine 150
RxNorm normalized name: imipramine pamoate 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine 150 mg
Trial: 31728715
Drug: Intermittent 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent 5 doses of filgrastim (5 mcg/kg/day)
Trial: 31728715
Drug: Once-a-cycle pegfilgrastim
RxNorm normalized name: Pegfilgrastim
DrugBank: Pegfilgrastim (DB00019)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Once-a-cycle pegfilgrastim (6 mg)
Trial: 22741253
Drug: Combination group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination group (electroacupuncture + Dalitong granule)
Trial: 31998163
Drug: Recreational Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recreational Therapy (RT)
Trial: 15662532
Drug: Storage in
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Storage in lactic acid solution for 3 days
Trial: 12869081
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 750 mg of intravenous cefuroxime
Trial: 12869081
Drug: Patients already
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients already receiving antibiotics for prior indications
Trial: 9477785
Drug: Hydroxyapatite-coated implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyapatite-coated implants
Trial: 10531745
Drug: Non-coated commercially
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-coated commercially pure titanium implants
Trial: 10159954
Drug: Passive hyperimmune
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Passive hyperimmune therapy
Trial: 8495871
Drug: Postoperative start
RxNorm normalized name: Star Anise Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative start of thromboprophylaxis with low molecular weight heparin
Trial: 3086899
Drug: Isosorbide 5-mononitrate
RxNorm normalized name: Isosorbide 5-mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide 5-mononitrate 40 mg twice daily
Trial: 3086899
Drug: Sustained-release isosorbide
RxNorm normalized name: isosorbide Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release isosorbide dinitrate 40 mg twice daily
Trial: 29485019
Drug: Directly observed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Directly observed hand hygiene (DOHH) performed at two-hourly intervals during daytime, before meals and medication rounds by a trained nurse.
Trial: 22180390
Drug: Virtual reality
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virtual reality cognitive-behavior therapy (VRCBT)
Trial: 20143246
Drug: Topiramate 25
RxNorm normalized name: topiramate 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 25 mg/day
Trial: 18677327
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy (part of a 4-year randomized controlled trial)
Trial: 8683230
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate 40 mg four times daily
Trial: 1874767
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of cefonicid (Group I)
Trial: 1874767
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of cefamandole (Group II)
Trial: 1874767
Drug: Five doses
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five doses of cefamandole (Group III)
Trial: 7097431
Drug: Pharmacotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy with imipramine hydrochloride
Trial: 19545211
Drug: Vaccine dose
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine dose of 1 X 10(4) ffu
Trial: 19545211
Drug: Vaccine dose
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine dose of 1 X 10(5) ffu
Trial: 15302293
Drug: metformin 850
RxNorm normalized name: metFORMIN 850 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metformin 850 mg two times per day
Trial: 15302293
Drug: lifestyle modification
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lifestyle modification plus metformin 850 mg two times per day
Trial: 9643401
Drug: Routine adoption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine adoption of HIV infection control guidelines during delivery (including protective glasses, impermeable garments, mask, sterile latex gloves, washing hands with detergent solution after using gloves, and collecting needles in suitable containers)
Trial: 8036463
Drug: Topical metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical metronidazole treatment (40-160 mg daily)
Trial: 25925729
Drug: Topical metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical metronidazole treatment
Trial: 31092443
Drug: S-1 (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1 (80 mg/m2) plus cisplatin (80 mg/m2) with bevacizumab (15 mg/kg) followed by maintenance with bevacizumab plus S-1 (SCB)
Trial: 31092443
Drug: Pemetrexed (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed (500 mg/m2) plus cisplatin (75 mg/m2) with bevacizumab (15 mg/kg) followed by maintenance with bevacizumab plus pemetrexed (PCB)
Trial: 21777229
Drug: Prednisolone (40-60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (40-60 mg/day for 2 weeks)
Trial: 9191638
Drug: Low-angle cases
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-angle cases (ML/NSL < 25 degrees)
Trial: 3930309
Drug: Miraxid (pivmecillinam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miraxid (pivmecillinam 200 mg plus pivampicillin 250 mg)
Trial: 3533674
Drug: Augmentin (amoxycillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmentin (amoxycillin 250 mg plus clavulanic acid 125 mg)
Trial: 31620856
Drug: Erector spinae
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erector spinae plane block (ESPB) with 30 ml 0.25% bupivacaine
Trial: 27472452
Drug: Cognitive Behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behaviour Therapy (CBT) for SPOV, 12 sessions
Trial: 22516357
Drug: Intravesical 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical 2% chondroitin sulfate (20 mL, 8 weekly instillations)
Trial: 22516357
Drug: Inactive control
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactive control solution (20 mL, 8 weekly instillations)
Trial: 22516357
Drug: Inactive control
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactive control solution
Trial: 12517682
Drug: perindopril 8
RxNorm normalized name: perindopril 8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: perindopril 8 mg
Trial: 12939564
Drug: felodipine 10
RxNorm normalized name: felodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: felodipine 10 mg
Trial: 12517682
Drug: hydrochlorothiazide 50
RxNorm normalized name: hydrochlorothiazide 50 MG
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: hydrochlorothiazide 50 mg
Trial: 9038465
Drug: Morphine sulphate
RxNorm normalized name: Morphine sulphate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulphate 10 mg orally pre-operatively
Trial: 6487753
Drug: Controlled-release formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release formulation of sodium salicylate (NaSA)
Trial: 6487753
Drug: Enteric-coated tablet
RxNorm normalized name: Walgreens Low Dose Aspirin 81mg Enteric-Coated Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated tablet of sodium salicylate (NaSA)
Trial: 6487753
Drug: Solution of
RxNorm normalized name: Solution of protein-free hemodialysate of calf blood
DrugBank: SM-1997 (DB18670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution of sodium salicylate (NaSA)
Trial: 29288141
Drug: Increased number
RxNorm normalized name: Derma Numb
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Increased number of medications
Trial: 22302127
Drug: Oral almorexant
RxNorm normalized name: Nemorexant
DrugBank: Daridorexant (DB15031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral almorexant 200 mg
Trial: 22302127
Drug: Intravenous almorexant
RxNorm normalized name: Nemorexant
DrugBank: Daridorexant (DB15031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous almorexant 20 mg
Trial: 20571832
Drug: Bupivacaine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (200 mg) with 0.5 mg epinephrine
Trial: 20571832
Drug: Levobupivacaine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine (200 mg) with 0.5 mg epinephrine
Trial: 16043829
Drug: Erlotinib 150
RxNorm normalized name: erlotinib 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 150 mg/d combined with carboplatin and paclitaxel
Trial: 9785782
Drug: Saline group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline group (n = 15) - received saline 10 ml injected through an epidural catheter 20 min after spinal anesthesia
Trial: 9785782
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (n = 15) - received 2% lidocaine 3 ml with 0.4% tetracaine injected into the subarachnoid space; saline was not injected into the epidural space
Trial: 8585716
Drug: Adefovir 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adefovir 1.0 mg/kg intravenous infusion
Trial: 8585716
Drug: Adefovir 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adefovir 3.0 mg/kg intravenous infusion
Trial: 8585716
Drug: Adefovir 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adefovir 1.0 mg/kg/day for 22 days
Trial: 8585716
Drug: Adefovir 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adefovir 3.0 mg/kg/day for 22 days
Trial: 8585716
Drug: Adefovir 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adefovir 3.0 mg/kg oral dose
Trial: 8585716
Drug: Adefovir 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adefovir 3.0 mg/kg subcutaneous dose
Trial: 31186150
Drug: ARA‐25 (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARA‐25 (25 g ARA/100 kcal, no added prebiotic blend)
Trial: 31186150
Drug: PDX/GOS (34
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PDX/GOS (34 mg ARA/100 kcal, with prebiotic blend)
Trial: 31186150
Drug: Control (34
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (34 mg ARA/100 kcal, no added prebiotic blend)
Trial: 16681586
Drug: Topical 5%
RxNorm normalized name: urea topical 5% topical lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 5% 5-FU ointment
Trial: 16681586
Drug: Placebo aqueous
RxNorm normalized name: Pen-Aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo aqueous cream
Trial: 14713798
Drug: 15 cc
RxNorm normalized name: OCTINOXATE 50 mg in 1 mL TOPICAL CREAM [flormar CC Magical Color Effect Color Correcting Cream Sunscreen Broad Spectrum SPF 15 CC02]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 cc 2% lidocaine gel administered intrarectally 10 minutes before biopsy
Trial: 14713798
Drug: 10 cc
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 cc 1% lidocaine under ultrasound guidance as 2 periprostatic injections of 5 cc 5 minutes prior to biopsy
Trial: 9863105
Drug: Ligustrazine (LGT)
RxNorm normalized name: ligustrazine
DrugBank: Ligustrazine (DB19074)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ligustrazine (LGT) administered by intravenous drip before occlusion and immediately after release
Trial: 3294815
Drug: trifluoperazine 1
RxNorm normalized name: trifluoperazine 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: trifluoperazine 1 mg b.i.d.
Trial: 3294815
Drug: haloperidol 0.5
RxNorm normalized name: haloperidol 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: haloperidol 0.5 mg b.i.d.
Trial: 19224089
Drug: Melatonin (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (9 mg sublingually)
Trial: 15117042
Drug: saline (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: saline (control group) and midazolam 7.5 mg given orally 30‐60 minutes before induction
Trial: 11281386
Drug: G-CSF-mobilized peripheral
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF-mobilized peripheral blood stem cell transplantation (BCT)
Trial: 7951550
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy with insulin and fluid administration
Trial: 27241991
Drug: Fluoride varnish
RxNorm normalized name: Hydrogen fluoride
DrugBank: Hydrogen fluoride (DB11072)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride varnish treatment once a month for 6 months
Trial: 27241991
Drug: Fluoride film
RxNorm normalized name: Hydrogen fluoride
DrugBank: Hydrogen fluoride (DB11072)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride film treatment once a month for 6 months
Trial: 24239143
Drug: Patient Benefit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient Benefit Index (PBI-L)
Trial: 8282334
Drug: cilazapril (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cilazapril (2.5 to 5 mg/d)
Trial: 17386354
Drug: atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol (50 to 100 mg/d)
Trial: 2643672
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg nicotine chewing gum
Trial: 3585679
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg nicotine chewing gum
Trial: 28917657
Drug: ATRA plus
RxNorm normalized name: ATRA
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ATRA plus danazol (10 mg twice daily + 200 mg twice daily)
Trial: 7577849
Drug: Danazol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol (200 mg twice daily)
Trial: 21324455
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist protocol with luteal phase E(2) patch
Trial: 19243357
Drug: Dexlansoprazole MR
RxNorm normalized name: Dexlansoprazole
DrugBank: Dexlansoprazole (DB05351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole MR 90 mg after fasting
Trial: 16954724
Drug: Zidovudine (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine (oral and intravenous dosing)
Trial: 16954724
Drug: Contraceptive therapy
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive therapy (oral or injectable)
Trial: 16954724
Drug: Zidovudine (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine (oral administration)
Trial: 16954724
Drug: Contraceptive therapy
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive therapy
Trial: 15159264
Drug: Subcutaneous adjusted-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous adjusted-dose unfractionated heparin (UFH)
Trial: 15159264
Drug: Fixed-dose low-molecular-weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose low-molecular-weight heparin (nadroparin)
Trial: 31435964
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of alfaxalone (10 mg/kg)
Trial: 31435964
Drug: Intravenous injection
RxNorm normalized name: Meta Trace FDG, intravenous injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous injection of alfaxalone (10 mg/kg)
Trial: 27009831
Drug: Daclatasvir (DCV)
DrugBank: Daclatasvir (DB09102)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Daclatasvir (DCV) 60 mg once daily plus Asunaprevir (ASV) 100 mg twice daily for 12 weeks
Trial: 18583470
Drug: Raloxifene 60
RxNorm normalized name: raloxifene 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 60 mg by mouth daily
Trial: 1550275
Drug: 1 ml
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml propofol (10 mg)
Trial: 1550275
Drug: 1 ml
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml placebo (Intralipid)